牛唐2021-03-31 09:44
$灿菲特生物制药(CANF)$ 的药物Piclidenoson和Namodenoson在现有的六份分销协议中,剩余的潜在里程碑付款高达约1.3亿美元,外加两位数的净销售额分成。$新泰医药(MDGL)$ $泰格医药(SZ300347)$查看全文
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-08-23 AccNo: 0001213900-17-009117 Size: 37 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-08-09 AccNo: 0001213900-17-008348 Size: 31 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-08-07 AccNo: 0001213900-17-008270 Size: 35 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: n Filed: 2017-08-01 AccNo: 0001213900-17-008101 Size: 17 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: n Filed: 2017-07-26 AccNo: 0001213900-17-007913 Size: 11 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: n Filed: 2017-07-19 AccNo: 0001213900-17-007719 Size: 11 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: i Filed: 2017-07-17 AccNo: 0001213900-17-007600 Size: 35 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-07-10 AccNo: 0001213900-17-007309 Size: 17 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-19 AccNo: 0001213900-17-006599 Size: 720 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2017-06-14 AccNo: 0001213900-17-006454 Size: 598 KB 网页链接